162 related articles for article (PubMed ID: 25967377)
1. Iron overload in transfusion-dependent thalassemia.
Saliba A; Taher A
Hematology; 2015 Jun; 20(5):311-2. PubMed ID: 25967377
[No Abstract] [Full Text] [Related]
2. Increasing prevalence of thalassemia in America: Implications for primary care.
Sayani FA; Kwiatkowski JL
Ann Med; 2015; 47(7):592-604. PubMed ID: 26541064
[TBL] [Abstract][Full Text] [Related]
3. Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): a status quo.
Taher AT; Musallam KM; Viprakasit V; Porter JB; Cappellini MD
Blood Cells Mol Dis; 2014; 52(2-3):88-90. PubMed ID: 24041597
[No Abstract] [Full Text] [Related]
4. Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose.
Pongtanakul B; Viprakasit V
Blood Cells Mol Dis; 2013 Aug; 51(2):96-7. PubMed ID: 23566753
[No Abstract] [Full Text] [Related]
5. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
Taher AT; Temraz S; Cappellini MD
Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
[TBL] [Abstract][Full Text] [Related]
6. MRI for Iron Overload in Thalassemia.
Fernandes JL
Hematol Oncol Clin North Am; 2018 Apr; 32(2):277-295. PubMed ID: 29458732
[TBL] [Abstract][Full Text] [Related]
7. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
Fragasso A; Ciancio A; Mannarella C; Gaudiano C; Scarciolla O; Ottonello C; Francone M; Nardella M; Peluso A; Melpignano A; Veglio MR; Quarta G; Turchetti C
Eur J Intern Med; 2011 Feb; 22(1):62-5. PubMed ID: 21238896
[TBL] [Abstract][Full Text] [Related]
8. MRI and iron-overload cardiomyopathy in thalassaemia.
Pennell D
Circulation; 2006 Mar; 113(11):f43-4. PubMed ID: 16552847
[No Abstract] [Full Text] [Related]
9. Myocardial fibrosis in thalassaemia: recalling the past or telling the future?
Carpenter JP; Prasad SK; Pennell DJ
Heart; 2009 Oct; 95(20):1646-7. PubMed ID: 19628469
[No Abstract] [Full Text] [Related]
10. Pituitary iron and factors predictive of fertility status in transfusion dependent thalassemia.
Singer ST; Fischer R; Allen I; Lal A; Vichinsky E; Yuan Q; Wang ZJ
Haematologica; 2021 Jun; 106(6):1740-1744. PubMed ID: 33121232
[TBL] [Abstract][Full Text] [Related]
11. Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis.
Singer ST; Killilea D; Suh JH; Wang ZJ; Yuan Q; Ivani K; Evans P; Vichinsky E; Fischer R; Smith JF
Am J Hematol; 2015 Sep; 90(9):E190-2. PubMed ID: 26044409
[No Abstract] [Full Text] [Related]
12. Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later.
Musallam KM; Cappellini MD; Viprakasit V; Kattamis A; Rivella S; Taher AT
Am J Hematol; 2021 Feb; 96(2):E54-E56. PubMed ID: 33219703
[No Abstract] [Full Text] [Related]
13. Non-Transfusion-Dependent Thalassemia: A Panoramic Review.
Shash H
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295656
[TBL] [Abstract][Full Text] [Related]
14. High nontransferrin bound iron levels and heart disease in thalassemia major.
Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
[TBL] [Abstract][Full Text] [Related]
15. Consensus document for transfusion-related iron overload.
Vichinsky E
Semin Hematol; 2001 Jan; 38(1 Suppl 1):2-4. PubMed ID: 11206957
[No Abstract] [Full Text] [Related]
16. Deferiprone (Ferriprox) for iron overload.
Med Lett Drugs Ther; 2012 Feb; 54(1384):15-6. PubMed ID: 22354281
[No Abstract] [Full Text] [Related]
17. [Secondary iron overload].
Galacteros F
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():44-8. PubMed ID: 9827215
[No Abstract] [Full Text] [Related]
18. Assessment and treatment of cardiac iron overload in thalassemia.
Aessopos A; Farmakis D; Andreopoulos A; Tsironi M
Hemoglobin; 2009; 33 Suppl 1():S87-92. PubMed ID: 20001638
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C virus infection in thalassemia.
Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
[TBL] [Abstract][Full Text] [Related]
20. Iron overload in β-thalassemia intermedia: an emerging concern.
Musallam KM; Cappellini MD; Taher AT
Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
